CUSIP 19240Q201 · who reports it, how much, and how much it matters to them
57 of the 720 hedge fund managers we track reported shares of Cogent Biosciences, Inc. (Nasdaq: COGT) on Form 13F for 30 June 2026. Between them they reported USD 1.4bn. The largest position belongs to Fairmount Funds Management, at USD 213m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Fairmount Funds Management2 funds on PPLI.com | USD 213m | 14.1% |
| 2 | Kynam Capital Management1 fund on PPLI.com | USD 142m | 7.8% |
| 3 | Polar Capital LLP26 funds on PPLI.com | USD 125m | 0.3% |
| 4 | Octagon Capital Advisors1 fund on PPLI.com | USD 91m | 8.2% |
| 5 | RTW Investments2 funds on PPLI.com | USD 89m | 0.8% |
| 6 | Deep Track Capital1 fund on PPLI.com | USD 77m | 1.1% |
| 7 | Orbimed Advisors1 fund on PPLI.com | USD 65m | 1.2% |
| 8 | Sofinnova Investments1 fund on PPLI.com | USD 40m | 2.1% |
| 9 | Renaissance Technologies13 funds on PPLI.com | USD 39m | 0.1% |
| 10 | Balyasny Asset Management25 funds on PPLI.com | USD 37m | 0.0% |
| 11 | D. E. Shaw & Co.15 funds on PPLI.com | USD 36m | 0.0% |
| 12 | Millennium Management6 funds on PPLI.com | USD 35m | 0.0% |
| 13 | Logos Global Management1 fund on PPLI.com | USD 35m | 1.5% |
| 14 | Citadel Advisors32 funds on PPLI.com | USD 33m | 0.0% |
| 15 | POINT72 Asset Management17 funds on PPLI.com | USD 29m | 0.0% |
| 16 | Marshall Wace LLP84 funds on PPLI.com | USD 27m | 0.0% |
| 17 | Boothbay Fund Management2 funds on PPLI.com | USD 27m | 0.4% |
| 18 | J. Goldman & Co.1 fund on PPLI.com | USD 25m | 0.6% |
| 19 | Rock Springs Capital Management2 funds on PPLI.com | USD 20m | 1.0% |
| 20 | Redmile Group10 funds on PPLI.com | USD 19m | 1.3% |
| 21 | Eversept Partners3 funds on PPLI.com | USD 19m | 1.0% |
| 22 | Sphera Funds Management1 fund on PPLI.com | USD 18m | 2.3% |
| 23 | Superstring Capital Management1 fund on PPLI.com | USD 13m | 8.4% |
| 24 | Burkehill Global Management5 funds on PPLI.com | USD 13m | 0.5% |
| 25 | Atika Capital Management3 funds on PPLI.com | USD 11m | 0.7% |
| 26 | Boxer Capital Management1 fund on PPLI.com | USD 8.7m | 0.7% |
| 27 | Exome Asset Management2 funds on PPLI.com | USD 8.1m | 5.0% |
| 28 | HighVista Strategies27 funds on PPLI.com | USD 7.3m | 1.7% |
| 29 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 6.5m | 0.0% |
| 30 | Platinum Investment Management11 funds on PPLI.com | USD 6m | 1.5% |
| 31 | Persistent Asset Partners10 funds on PPLI.com | USD 5.4m | 1.6% |
| 32 | Perceptive Advisors6 funds on PPLI.com | USD 4.7m | 0.1% |
| 33 | Verition Fund Management3 funds on PPLI.com | USD 4.1m | 0.0% |
| 34 | Cormorant Asset Management1 fund on PPLI.com | USD 3.9m | 0.2% |
| 35 | Bleichroeder4 funds on PPLI.com | USD 3.9m | 0.7% |
| 36 | Sona Asset Management (US)1 fund on PPLI.com | USD 3.1m | 0.1% |
| 37 | Brevan Howard Capital Management39 funds on PPLI.com | USD 2.7m | 0.0% |
| 38 | Atom Investors1 fund on PPLI.com | USD 2.5m | 0.2% |
| 39 | Sculptor Capital67 funds on PPLI.com | USD 1.9m | 0.0% |
| 40 | LMR Partners2 funds on PPLI.com | USD 1.9m | 0.0% |
| 41 | Adage Capital Management1 fund on PPLI.com | USD 1.9m | 0.0% |
| 42 | Cinctive Capital Management5 funds on PPLI.com | USD 1.7m | 0.1% |
| 43 | Capricorn Fund Managers8 funds on PPLI.com | USD 1.6m | 0.1% |
| 44 | Two Sigma Investments35 funds on PPLI.com | USD 1.5m | 0.0% |
| 45 | Jain Global1 fund on PPLI.com | USD 1.4m | 0.0% |
| 46 | Holocene Advisors2 funds on PPLI.com | USD 1.3m | 0.0% |
| 47 | Capital Fund Management S.A.12 funds on PPLI.com | USD 1.1m | 0.0% |
| 48 | Farallon Capital Management56 funds on PPLI.com | USD 658,000 | 0.0% |
| 49 | Aquatic Capital Management3 funds on PPLI.com | USD 516,000 | 0.0% |
| 50 | Scientech Research2 funds on PPLI.com | USD 510,000 | 0.4% |
| 51 | Engineers Gate Manager1 fund on PPLI.com | USD 475,000 | 0.0% |
| 52 | Entrypoint Capital1 fund on PPLI.com | USD 430,000 | 0.1% |
| 53 | Magnetar Financial93 funds on PPLI.com | USD 360,000 | 0.0% |
| 54 | Verdad Advisers6 funds on PPLI.com | USD 221,000 | 0.2% |
| 55 | CIBC Asset Management69 funds on PPLI.com | USD 202,000 | 0.0% |
| 56 | Bayforest Capital1 fund on PPLI.com | USD 90,055 | 0.1% |
| 57 | The Quarry1 fund on PPLI.com | USD 271 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Fairmount Funds Management | USD 213m | 14.1% |
| 2 | Superstring Capital Management | USD 13m | 8.4% |
| 3 | Octagon Capital Advisors | USD 91m | 8.2% |
| 4 | Kynam Capital Management | USD 142m | 7.8% |
| 5 | Exome Asset Management | USD 8.1m | 5.0% |
| 6 | Sphera Funds Management | USD 18m | 2.3% |
| 7 | Sofinnova Investments | USD 40m | 2.1% |
| 8 | HighVista Strategies | USD 7.3m | 1.7% |
| 9 | Persistent Asset Partners | USD 5.4m | 1.6% |
| 10 | Logos Global Management | USD 35m | 1.5% |
Cogent Biosciences, Inc. trades under the symbol COGT on the Nasdaq. Its CUSIP, the code used on Form 13F, is 19240Q201.
57 of the 720 hedge fund managers PPLI.com tracks reported Cogent Biosciences, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Fairmount Funds Management (USD 213m), Kynam Capital Management (USD 142m), Polar Capital LLP (USD 125m), Octagon Capital Advisors (USD 91m) and RTW Investments (USD 89m).
57 managers in our coverage reported it, and between them they run 758 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Fairmount Funds Management, where the position was 14.1% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Cogent Biosciences, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.